From KXYL: Spokane Community College Partners with Company to Train Biomanufacturing Workers
"We're not just creating jobs. We want to create careers." Spokane Community College partnered with Jubilant HollisterStier to launch a biomanufacturing training program this semester. The curriculum covers basic biomanufacturing operations. Students learn skills that...
Jubilant HollisterStier, Community College Partner on Program to Fill Workforce Pipeline
From the Spokane Journal of Business Jubilant HollisterStier LLC, HollisterStier Allergy, and Spokane Community College are partnering to develop a specialized training program to prepare students for careers in pharmaceutical manufacturing. A 10-week pilot program,...
Jubilant HollisterStier Awarded Manufacturer of the Year from the Association of Washington Business
Life Science Washington, an independent, non-profit trade association serving the life sciences industry in the state of Washington, notes Jubilant HollisterStier's win as the Association of Washington Business (AWB) 2024 Manufacturer of the Year.
Jubilant HollisterStier: Scaling Excellence in Pharma Manufacturing
Jubilant HollisterStier CMO is making significant strides in expanding its capabilities to meet global demand for complex formulations and sterile injectables. In this interview with Contract Pharma, CEO Chris Preti shares insights into the company’s ongoing...
Exploring CMO Strategies with Chris Preti (DCAT Week)
In June of 2023, Chris Preti, CEO of Jubilant HollisterStier CMO, met with Grant Playter, associate editor of Pharmtech.com, at the 2023 DCAT Week conference. Topics of discussion include operations and the strategic vision at Jubliant HollisterStier, the current...
Jubilant HollisterStier Appoints Chris Preti President
On March 16 2023, Contract Pharma sat down and interviewed Chris Preti, when he was appointed as president of Jubilant HollisterStier. Chris Preti has more than 25 years of pharmaceutical industry experience and has been the recent president of HollisterStier Allergy....
Jubilant HollisterStier to Pump $76M into Montreal Facility
On July 14 2021, Fierce Pharma reported on the $76Mn expansion of the Jubilant HollisterStier CDMO facility in Montreal, Canada. This investment doubled the facility’s drug production capacity and added new, specialized equipment to be used in production.
Jubilant HollisterStier, Lilly Enter Bamlanivimab Mfg. Pact
In March 2021, during the height of the COVID-19 pandemic, Contract Pharma wrote an article detailing Jubilant HollisterStier’s contract with Eli Lilly to manufacture a therapeutic COVID-19 treatment. This contract is one example of how JHS assisted in producing both...
Elevating Your Vision with Personalized Support
Contact us today and let’s explore how we can support your next project.